| Literature DB >> 26703750 |
Mythili Prakasam1, Janis Locs2, Kristine Salma-Ancane3, Dagnija Loca4, Alain Largeteau5, Liga Berzina-Cimdina3.
Abstract
In the last five decades, there have been vast advances in the field of biomaterials, including ceramics, glasses, glass-ceramics and metal alloys. Dense and porous ceramics have been widely used for various biomedical applications. Current applications of bioceramics include bone grafts, spinal fusion, bone repairs, bone fillers, maxillofacial reconstruction, etc. Amongst the various calcium phosphate compositions, hydroxyapatite, which has a composition similar to human bone, has attracted wide interest. Much emphasis is given to tissue engineering, both in porous and dense ceramic forms. The current review focusses on the various applications of dense hydroxyapatite and other dense biomaterials on the aspects of transparency and the mechanical and electrical behavior. Prospective future applications, established along the aforesaid applications of hydroxyapatite, appear to be promising regarding bone bonding, advanced medical treatment methods, improvement of the mechanical strength of artificial bone grafts and better in vitro/in vivo methodologies to afford more particular outcomes.Entities:
Keywords: bioceramics; biomaterials; dense ceramics; hydroxyapatite; properties
Year: 2015 PMID: 26703750 PMCID: PMC4695913 DOI: 10.3390/jfb6041099
Source DB: PubMed Journal: J Funct Biomater ISSN: 2079-4983
Figure 1Cross-section of human bone morphology [19].
Figure 2Cells of osseous tissue [20].
Mechanical properties of bone tissues [21,22,23,24].
| Type of Bone | Compression Resistance (MPa) | Flexion Resistance (MPa) | Tension Resistance (MPa) | Modulus (GPa) | Porosity (%) |
|---|---|---|---|---|---|
| Cortical | 130–180 | 135–193 | 50–151 | 12–18 | 5–13 |
| Spongy | 4–12 | – | 1–5 | 0.1–0.5 | 30–90 |
Ceramics used in biomedical applications.
| Ceramic | Chemical Formula | Usage |
|---|---|---|
| Alumina | Al2O3 | Bioinert |
| Zirconia | ZrO2 | |
| Pyrolytic carbon | Py-C | |
| Bioglass | Na2OCaOP2O3-SiO | Bioactive |
| Hydroxyapatite (sintered at high temperature) | Ca10(PO4)6(OH)2 | |
| Hydroxyapatite ( sintered at low temperature) | Ca10(PO4)6(OH)2 | Biodegradable |
| Tricalcium phosphate | Ca3(PO4)2 |
Mechanical properties of ceramic biomaterials [19,25,26,27].
| Name | Young’s Modulus E (GPa) | Compressive Strength σ (MPa) | Tensile Strength σ (MPa) |
|---|---|---|---|
| Alumina | 380 | 4500 | 350 |
| Bioglass-ceramics | 22 | 500 | 56–83 |
| Calcium phosphates | 40–117 | 510–896 | 69–193 |
| Pyrolytic carbon | 18–28 | 517 | 280–560 |
Principal calcium phosphates used as biomaterials. HAp, hydroxyapatite.
| Name and Chemical Formula | Crystal Structure | Density | Usage |
|---|---|---|---|
| Monocalcium phosphate monohydrate Ca(H2PO4)2·H2O | Triclinic | 2.23 | In solution: as liquid phase in certain cements |
| Anhydrous monocalcium phosphate Ca(H2PO4)2 | Triclinic | 2.57 | In solution: as liquid phase in certain cements |
| Dicalcium phosphate dihydrate CaHPO4·2H2O | Monoclinic | 2.30 | Thin deposits, cements and composites |
| Dicalcium phosphate anhydrous CaHPO4 | Triclinic | 2.93 | Thin deposits, cements and composites |
| Amorphous Tricalcium phosphate Ca3(PO4)2·nH2O | Three polymorphs based on temperature | – | Thin deposits, cements and composites |
| Octocalcium phosphate Ca8(PO4)4(HPO4)2·5H2O | Triclinic | 2.67 | Cements |
| Tricalcium phosphate β Ca3(PO4)2 | Rhombohedral | 3.07 | Resorbable bioceramics, cements, composites |
| Tricalcium phosphate α Ca3(PO4)2 | Monoclinic | 2.86 | Resorbable bioceramics, cements, composites |
| Tetracalcium phosphate Ca4(PO4)2O | Monoclinic | 3.05 | Cements |
| Hydroxyapatite phospho-calcium Ca10(PO4)6(OH)2 | Hexagonal (the stoichiometric HAp is monoclinic at temperatures <212 °C, whereas in other cases, the small quantities of impurities lead to a change from monoclinic to hexagonal) | 3.16 | Cements, composites, ceramics and thin films |
Figure 3Sintering stages from powder to densification.
Figure 4Viewport with and yttria-stabilized ZrO2 (YSZ) transparent ceramic for a human skull.
Figure 5Comparison of the X-ray diffractograms of commercial HAp powders with a grain size of 50 nm and their sintered pellets in addition to HAp sintered pellets from synthesized HAp powders (~20 nm). SPS, spark plasma sintering.
Figure 6(a) Commercial HAp-SPS sintered at 900 °C, 10 min; (b) synthesized needle-shaped HAp-SPS sintered at 900 °C, 10 min.
Figure 7Fabricated transparent ceramics of hydroxyapatite with different grain morphologies.